FEDERAL “RELATED SCIENCE ACTIVITIES” (RSA) AND MULTI-LEVEL REGULATION  INTRODUCTION AND CENTRAL PURPOSES  RSA AND LEVELS OF SCIENCE-BASED REGULATION.

Slides:



Advertisements
Similar presentations
Distance Education and Active Learning -One Approach to Support Succession Planning Aram Attarian, Ph.D North Carolina State University Department of Parks,
Advertisements

Engineering Leadership
Inspection experiences Dr Sandy Mather Director of Regulation.
Professional Certificate in Leadership and Management - Certificate in Electoral Processes 9 th – 13 th July 2012 Guide to Planning for Electoral Management.
Proposed Ontario Agency for Health Protection and Promotion Update on Agency Implementation Presentation for: Ontario Society of Nutrition Professionals.
Administration, Management, and Coordination of Supportive Housing: Guidelines from CSH’s Dimensions of Quality MHSA TA Operations Call September 1, 2010.
Dr. Michael E. Oehlsen International Policy Analyst International Programs Team - Office of the Director Center for Veterinary Medicine Food and Drug Administration.
Regulatory Compliant Performance Improvement for Pharmaceutical Plants AIChE New Jersey Section 01/13/2004 Murugan Govindasamy Pfizer Inc.
Continuous Improvement Objectives Pillar Workshop 2009.
Presentation By: Chris Wade, P Eng. Finally … a best practice for selecting an engineering firm.
Achieving Continuous Improvement in Client Satisfaction
ONDQA Perspective on Post Approval Changes Eric P. Duffy, PhD Director, Division of Post-Market Evaluation, ONDQA, CDER, FDA Public Meeting: Supplements.
Environmental Management Services
FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
Presentation by Ida Ngueng Feze Esq. Centre of Genomics and Policy, McGill University.
Health and Safety Executive Health and Safety Executive Discretion and Judgement: HSE’s approach Mike Cross 3 June 2014.
Reporting to consumers - International, national and local experience Principles, guidelines and practical steps Hilary Russell Director - Development,
OFFICIAL CONTROL OF FOOD LABELLING AND FOOD QUALITY CONTROL Dr. Pirjo-Liisa Penttilä Ministry of Agriculture and Forestry Finland.
Tangible Construction Market and the On-line Monitoring System.
The Institutionalization of Business Ethics
Equity Housing Group Risk Management. 05 August 2002 © MazarsEquity Housing Group: Risk Management 2 Agenda Introduction: what is Risk Management? The.
Business Analysis: A Business Unit Perspective International Institute of Business Analysis January 18, 2012.
Implementation of ISO 14001/OHSAS TMS Consultancy Ltd.
Pharmacovigilance obligations of the Pharmaceutical companies in India
SécuriFerme Canada FarmSafe A strategy to bring safety and health to farm business risk management.
Process Management Auditing Version JP.10.1-UK Oct 03  The High Performance Organisation Ltd.
INTRODUCTION TO RA.
Implementing Shared Inspection Management Systems Insights from recent WBG research John R. Wille WBG Investment Climate Advisory Services Amman, Jordan.
1 Secure Commonwealth Panel Health and Medical Subpanel Debbie Condrey - Chief Information Officer Virginia Department of Health December 16, 2013 Virginia.
Prepared for; Conference on Multi-Level Regulatory Governance in Canada Addressing; Multi-Level Regulatory Governance in the Health Sector Prepared by;
TRP Chapter Chapter 3.1 Regulatory approaches.
INTITUTIONAL AUDIT & (SELF)-ACCREDITATION Ton Vroeijenstijn.
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. REGULATORY INTELLIGENCE: INDUSTRY’S BEST PRACTICE OMICS 5 th International Pharmaceutical.
Nano Draft Guidance and Pilot Projects Rob Visser UNITAR Senior Advisor Nano African Regional Meeting April 2011, Nairobi.
ANZI/AIHA Z Occupational Health and Safety Management Systems.
Environmental Management System Definitions
Copyright © 2007 Pearson Education Canada 1 Chapter 1: The Demand for Auditing and Assurance Services.
Chapter 25 Management and Policy Copyright 2004 by Delmar Learning, a division of Thomson Learning, Inc. Quality in Healthcare: A Glimpse of the.
Strengthening Risk Prevention and Consultation Mechanisms.
Registering the care sector – next steps Dr Linda Hutchinson Director, Care Quality Commission National Care Association Conference, 21 October 2010.
PhRMA Perspective on FDA Final Report FDA Advisory Committee on Pharmaceutical Sciences October 20, 2004 G.P. Migliaccio, Pfizer Inc.
Biologics and Genetic Therapies Directorate Health Products and Food Branch HEALTH CANADA Helping Canadians maintain and improve their health. Agnes Klein.
Safety Management System Implementation Michael Niels Thorsen Moscow 15 September 2005.
Professionalism: The inspectors competency model – why and how.
New England Vocational Rehabilitation Quality Assurance System
The Post-MiFID Financial World László Seregdi June 15, 2007 Split.
1 The Indiana Department of Correction presents New Employee Orientation: Vision and Mission Statements.
Joint Priority Project #2: Service Visions and Mapping Presentation to PSSDC/PSCIOC Winnipeg, Manitoba, September 28, 2004 By: Industry Canada Ontario.
Title Page Quality Mo Samimi, Ph.D. CMQ/OE Presented at the ASQ Biomedical Division Northern California Discussion Group. May 2011.
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.
Health Canada’s Approach to Low Risk Veterinary Health Products: Interim Notification Pilot Program Veterinary Drugs Directorate-Health Canada Presented.
Internal Audit Section. Authorized in Section , Florida Statutes Section , Florida Statutes (F.S.), authorizes the Inspector General to review.
Center for Food Safety and Applied Nutrition Systems Recognition Import System Public Meeting March 21, 2016 Caroline Smith DeWaal International Food Safety.
The International Society for Quality in Health Care (ISQua) – Guidelines.
1 Improving the agenda for SWITCH for nonprescription Medicines Sheila Kelly WSMI September 2015.
Global harmonisation versus national regulatory considerations.
Regulatory Updates Health Sciences Authority Singapore
State Steering Committee
The Institutionalization of Business Ethics
Department of Water and Environmental Regulation
World Health Organization
Better enforcement – the next step for regulatory policy
CDRH 2010 Strategic Priorities
Conflict of Interest in Research
Innovative Medicines Initiative:
FDA Resources and Meetings
Pharmaceutical Industry Feedback HPRA Performance
SPR-B Research Coordination Webinar
Presentation transcript:

FEDERAL “RELATED SCIENCE ACTIVITIES” (RSA) AND MULTI-LEVEL REGULATION  INTRODUCTION AND CENTRAL PURPOSES  RSA AND LEVELS OF SCIENCE-BASED REGULATION  CASE STUDY AGENCIES -VETERINARY DRUGS DIRECTORATE (Health Canada) -NEW SUBSTANCES BRANCH (Environment Canada)  CONCLUSIONS

RSA AND LEVELS OF SCIENCE- BASED REGULATION  RSA DEFINITIONS, RELATIONSHIPS AND BOUNDARIES  RSA IN FEDERAL S&T AND INNOVATION POLICY  RSA IN THE SMART REGULATION AGENDA

MAPPING RSA IN MULTI-LEVEL REGULATION  REGULATION AND ITS SERVICE RELATIONSHIPS: THE TRIAD OF - CLIENTS/CUSTOMERS - SERVICE PROVIDERS - SERVICE MEDIUMS TANGIBLE GOODS CODIFIED KNOWLEDGE INDIVIDUALS  REGULATION AS RULES AND COMPLIANCE  MAPPING RSA IN - PRE-MARKET PRODUCT OR OTHER APPROVALS - MONITORING (GENERAL AND POST-MARKET)

Table 1: Core RSA Relations in Multi-level Regulation a) RSA for Regulation and Product Approvals –direct assessment by RSA staff of products for approval/use in markets. –direct assessments/actions on compliance and enforcement –drafting of guidelines and guideline documents for use by client groups, and users of products in the general public and by employees of other levels of government –continuous exchange of RSA knowledge with international and foreign regulators.

b) RSA for General and Post-Market Monitoring –general and continuous surveys and monitoring –specific or targeted monitoring and reporting (e.g. pharmacovigilence) –not regulatory in the first instance but can tie into or lead to other regulations by other governments or self- regulation by stakeholders; –can produce guidelines and actions which citizens perceive as regulatory in some overall sense of the state as protector of health and safety –involves numerous exchanges of RSA knowledge amongst staff in other core federal, provincial and international agencies as well as professional knowledge groups.

THE CASE STUDY AGENCIES AND MULTI- LEVEL REGULATION  RSA IN HEALTH CANADA AND ENVIRONMENT CANADA  CORE MANDATES -VETERINARY DRUGS DIRECTORATE -NEW SUBSTANCES BRANCH  CORE DECISION AND RISK ASSESSMENT AND MANAGEMENT CYCLES AND VOLUMES  RSA PARTNERSHIPS AND DEPENDENCIES  RSA PERSONNEL BACKGROUNDS AND COMPETENCES

CONCLUSIONS  RSA NEEDS TO MORE CLEARLY UNDERSTOOD AS CRUCIAL TO REGULATION AND MULTI-LEVEL REGULATION  RSA HAS BEEN SYSTEMICALLY UNDERPLAYED IN FEDERAL S&T, INNOVATION AND SMART REGULATION POLICY  THE FEDERAL GOVERNMENT IS CONTINUOUSLY INCREASING ITS OWN AND CANADA’S MULTI-LEVEL NEEDS FOR RSA BUT IT IS NOT SUPPORTING IT OR INVESTING IN IT WITH